Home » Medical Devices » Veterinary Pain Management Market

Veterinary Pain Management Market By Product Type (Drugs, Devices), By Application (Degenerative diseases, Post-surgical orthopedic complexities, Neurologic impairments, Chronic musculoskeletal laxity, Dermatologic diseases, Postchemotherapy gastrointestinal disease) – Growth, Future Prospects and Competitive Analysis 2018-2026

Summary
Table Of Content

Market Insights

The veterinary pain management market was worth US$ 1,078.5 million in 2017 and is expected to grow at a 7.9% CAGR from 2018 to 2026. rising humanization of animals due to the developing trend of nuclear families, continuous development in research and development activities related to veterinary pain management, and scheduled diagnostic sessions for livestock to maintain the quality of the meat, milk, and other products. Improper feeding and unorganized health management of pets and livestock animals lead to obesity, which eventually leads to joint pain and other disorders. In addition to that, pet and livestock owners are also being counseled and trained by non-government organizations or veterinary doctors to manage the health of their animals.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Synopsis

Drugs are preferred for their instant and target-specific therapeutic effects in managing pain in pets and livestock.

The drugs preferred in pain management are opioids, 2-adrenergic agonists, non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs, and others, including sedatives and corticosteroids. As a result, the drug of choice is determined by the type of disease and the intensity of pain. Drugs have been and will continue to be the primary method of pain management in veterinary medicine. The key factors responsible for the growth of the drugs segment are the rising prevalence of pain-inducing disorders, increasing advancements in clinical trials for veterinary pain management, and the wide range of drug options that provide flexibility to veterinary doctors to manage pain management.

Increasing humanization of pets and rising awareness related to the diagnosis and treatment of livestock in Asian countries will drive the market for veterinary pain management.

Asia Pacific is expected to grow significantly throughout the forecast period from 2018 to 2026. The major market drivers assisting its growth are the rising prevalence of degenerative diseases in Asia, rising awareness related to the diagnosis and treatment of diseases affecting pets and livestock, and rising adoption and humanization of pets, which are trending in Asian countries. According to industry experts, every year in India, around 600,000 pets (as of 2016) are adopted, and the rising population of pets has opened several opportunities for occupations and businesses related to pet healthcare in the country. According to the National Bureau of Statistics of China, in 2014, China had 27.4 million pet dogs and 58.1 million pet cats. Thus, India and China were observed as the most promising and potential veterinary pain management markets in the near future.

Periods of History and Forecast

The veterinary pain management market was analyzed considering current market trends for the base year of 2017, and based on future trends, CAGRs were calculated for the forecast period from 2018 to 2026.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Report Scope by Segments

This report provides an in-depth analysis related to the veterinary pain management market, including market interpretations and conclusions presented based on qualitative and quantitative data extracted through secondary and primary research. Industry experts have helped to analyze and derive market drivers, opportunities, and challenges further narrowed down to region- and country-level. This report also includes a detailed analysis of the global veterinary pain management market, which is segmented by product type, application, and geography. The report also provides a competitive analysis of the key players present in the veterinary pain management market that covers in-depth data related to the companies, along with the latest business strategies and product profiles.

The major companies present in the market are profiled based on their product portfolios, latest market updates, financial information, and key strategies. This report also covers attractive investment propositions analyzed with the assistance of comprehensive geographical research based on PESTEL analysis. Key companies analyzed in the report are Zoetis, Chanelle Veterinary Limited, Assisi Animal Health, Boehringer Ingelheim, Merck Animal Health, Vetoquinol, Norbrook, Elanco, Ceva Santé Animale, Bayer, K-Laser, and Dechra Pharmaceuticals, among others.

Key questions are answered in this report.

Which is the trending product type in the market preferred for veterinary pain management, and why?
What are the recent market strategies applied by key players and the competitive analysis specific to the veterinary pain management market?
Which are the major geographical markets (regions and countries) in the veterinary pain management market?
Which are the largest and fastest-growing intracranial stent types globally?
How is the competitive landscape of the veterinary pain management market and the policies of major players in this industry?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global VPM Market Portraiture
2.2. Global VPM Market, by Type of Product, 2017 (US$ Mn)
2.3. Global VPM Market, by Type of Application, 2017 (US$ Mn
2.4. Global VPM Market, by Geography, 2017 Vs 2026 (Value %)

Chapter 3. Global Veterinary Pain Management (VPM) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.2.1. Increasing prevalence of degenerative diseases in pets & farm animals
3.2.2. Rising awareness related to the diagnosis & treatment of pain-inducing diseases & conditions
3.3. Challenges
3.3.1. Lack of early diagnosis & minimum penetration in rural & remote parts of South America, Asia & Africa
3.4. Opportunities
3.4.1. Ongoing technological advancements in the field of veterinary diagnosis & treatment expected to assist the growth & penetration of VPM market
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Veterinary Pain Management (VPM) Market, by Type of Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Drugs
4.2.1. Opioids
4.2.2. α2-adrenergic Agonists
4.2.3. Local Anesthetics
4.2.4. Nonsteroidal Anti-inflammatory Drugs (NSIDs)
4.2.5. Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
4.2.6. Others (Sedatives, Corticosteroids etc.)
4.3. Devices
4.3.1. Laser Therapy
4.3.2. Electromagnetic Therapy

Chapter 5. Global Veterinary Pain Management (VPM) Market, by Type of Application, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Degenerative diseases (e.g., osteoarthritis, Cushing’s disease)
5.3. Post-surgical orthopedic complexities
5.4. Neurologic impairments
5.5. Chronic musculoskeletal laxity
5.6. Dermatologic diseases
5.7. Postchemotherapy gastrointestinal disease

Chapter 6. Global Veterinary Pain Management (VPM) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America VPM Market Analysis, 2016 – 2026
6.2.1. North America VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.2.2. North America VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.2.3. North America VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe VPM Market Analysis, 2016 – 2026
6.3.1. Europe VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.3.2. Europe VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.3.3. Europe VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific VPM Market Analysis, 2016 – 2026
6.4.1. Asia Pacific VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.4.2. Asia Pacific VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.4.3. Asia Pacific VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America VPM Market Analysis, 2016 – 2026
6.5.1. Latin America VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.5.2. Latin America VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.5.3. Latin America VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) VPM Market Analysis, 2016 – 2026
6.6.1. Middle East & Africa VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.6.2. Middle East & Africa VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.6.3. MEA VPM Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Boehringer Ingelheim
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Zoetis
7.3. Elanco
7.4. Merck Animal Health
7.5. Bayer
7.6. Vetoquinol
7.7. Norbrook Laboratories
7.8. Ceva Santé Animale
7.9. Dechra Pharmaceuticals
7.10. Chanelle
7.11. K-Laser USA
7.12. Assisi Animal Health

List of Figures

FIG. 1 Veterinary Pain Management (VPM): Market Segmentation
FIG. 2 Global VPM Market Share, by Type of Product, 2017 (US$ Mn)
FIG. 3 Global VPM Market Share, by Type of Application, 2017 (US$ Mn)
FIG. 4 Global VPM Market, by Geography, 2017 Vs 2026 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2017
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Opioids Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 8 Global α2-adrenergic Agonists Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 9 Global Local Anesthetics Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 10 Global Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for VPM Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Disease-Modifying Anti-Rheumatic Drugs (DMARDs) for VPM Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Other Drugs Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 13 Global Laser Therapy Devices Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 14 Global Electromagnetic Therapy Devices Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 15 Global VPM Market for Degenerative Diseases, 2016 – 2026 (US$ Mn)
FIG. 16 Global VPM Market for Post-surgical Orthopedic Complexities, 2016 – 2026 (US$ Mn)
FIG. 17 Global VPM Market for Neurologic Impairments, 2016 – 2026 (US$ Mn)
FIG. 18 Global VPM Market for Chronic Musculoskeletal Laxity, 2016 – 2026 (US$ Mn)
FIG. 19 Global VPM Market for Dermatologic Diseases, 2016 – 2026 (US$ Mn)
FIG. 20 Global VPM Market for Post-chemotherapy Gastrointestinal Disease, 2016 – 2026 (US$ Mn)
FIG. 21 U.S. VPM Market, 2016 – 2026 (US$ Mn)
FIG. 22 Canada VPM Market, 2016 – 2026 (US$ Mn)
FIG. 23 U.K. VPM Market, 2016 – 2026 (US$ Mn)
FIG. 24 Germany VPM Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest Of Europe VPM Market, 2016 – 2026 (US$ Mn)
FIG. 26 Japan VPM Market, 2016 – 2026 (US$ Mn)
FIG. 27 China VPM Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest Of Asia Pacific VPM Market, 2016 – 2026 (US$ Mn)
FIG. 29 Brazil VPM Market, 2016 – 2026 (US$ Mn)
FIG. 30 Mexico VPM Market, 2016 – 2026 (US$ Mn)
FIG. 31 Rest Of Latin America VPM Market, 2016 – 2026 (US$ Mn)
FIG. 32 GCC VPM Market, 2016 – 2026 (US$ Mn)
FIG. 33 Rest Of Middle East And Africa VPM Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Veterinary Pain Management (VPM) Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 2 Global VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 3 North America VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 4 North America VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 5 North America VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 6 Europe VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 7 Europe VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 8 Europe VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East & Africa VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 16 Middle East & Africa VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East And Africa VPM Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 18 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Zoetis: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Elanco: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Merck Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Bayer: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Vetoquinol: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Norbrook Laboratories : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Ceva Santé Animale: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Dechra Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Chanelle: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 K-Laser USA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Assisi Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Frequently Asked Questions:

What is the size of Veterinary Pain Management Market?

The market for Veterinary Pain Management Market is expected to reach US$ 1,078.5 Mn in 2026.

What is the Veterinary Pain Management Market CAGR?

The Veterinary Pain Management Market is expected to see significant CAGR growth over the coming years, at 7.9%.

What is the Forecast period considered for Veterinary Pain Management Market?

The report is forecasted to 2018-2026.

What is the base year considered for Veterinary Pain Management Market?

The base year of this report is 2017.

Who are the major players in this Market?

Boehringer Ingelheim, Zoetis, Elanco, Merck Animal Health, Bayer are some of the major players in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –